The metastasis suppressor NME1 regulates expression of genes linked to metastasis and patient outcome in melanoma and breast carcinoma

Cancer Genomics and Proteomics

Volumn 11, Issue 4, 2014, Pages 175-194

  McCorkle, Joseph R ^a   Leonard, Mary K ^b   Kraner, Susan D ^d   Blalock, Eric M ^d   Ma, Deqin ^e   Zimmer, Stephen G ^f   Kaetzel, David M ^b,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^f NONE

Author keywords

Adenovirus; Melanoma; Metastasis; Metastasis suppressor; Microarray; NDPK; NM23; NME1; Thyroid carcinoma

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN 2; COLONY STIMULATING FACTOR RECEPTOR; COLONY STIMULATING FACTOR RECEPTOR 2B; INTERSTITIAL COLLAGENASE; ONCOPROTEIN; PROTEIN SERPINB9; UNCLASSIFIED DRUG; NME1 PROTEIN, HUMAN; NUCLEOSIDE DIPHOSPHATE KINASE NM23;

ARTICLE; BREAST CARCINOMA; CANCER CELL LINE; CANCER PATIENT; CANCER PROGNOSIS; CCR1 GENE; CHEMOTAXIS; CSFR2B GENE; DISEASE FREE SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; FOCAL ADHESION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC LINKAGE; GPR52 GENE; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; MELANOMA; METASTASIS; MICROARRAY ANALYSIS; MORPHOGENESIS; MSF4A1 GENE; NME1 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PFN1 GENE; PPM1E GENE; RNA ANALYSIS; SERPINB9 GENE; SIGNAL TRANSDUCTION; STRESS FIBER; TBX4 GENE; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE; ZFP36L2 GENE; ZYX GENE; ADENOVIRIDAE; BREAST TUMOR; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION; GENE VECTOR; GENETICS; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; THYROID TUMOR; TUMOR CELL LINE;

ADENOVIRIDAE; BREAST NEOPLASMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; MELANOMA; NEOPLASM METASTASIS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PATIENT OUTCOME ASSESSMENT; PROGNOSIS; THYROID NEOPLASMS;

EID: 84921947528     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Smith SC and Theodorescu D: Learning therapeutic lessons from metastasis suppressor proteins. Nat Rev Cancer 9: 253-264, 2009.
2. Hurst DR and Welch DR: Metastasis suppressor genes at the interface between the environment and tumor cell growth. Int Rev Cell Mol Biol 286: 107-180, 2011.
3. Steeg PS and Theodorescu D: Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol 5: 206-219, 2008.
4. Jarrett SG, Novak M, Dabernat S, Daniel JY, Mellon I, Zhang Q, Harris N, Ciesielski MJ, Fenstermaker RA, Kovacic D, Slominski A and Kaetzel DM: Metastasis suppressor NM23-H1 promotes repair of UV-induced DNA damage and suppresses UV-induced melanomagenesis. Cancer Res 72: 133-143, 2012.
5. Ma D, McCorkle JR and Kaetzel DM: The metastasis suppressor NM23-H1 possesses 3'-5' exonuclease activity. J Biol Chem 279: 18073-18084, 2004.
6. Zhang Q, McCorkle JR, Novak M, Yang M and Kaetzel DM: Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity. Int J Cancer 128: 40-50, 2011.
7. Postel EH, Berberich SJ, Flint SJ and Ferrone CA: Human cmyc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science 261: 478-480, 1993.
8. Ma D, Nutt CL, Shanehsaz P, Peng X, Louis DN and Kaetzel DM: Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors. Cancer Res 65: 5523-5534, 2005.
9. Cervoni L, Egistelli L, Eufemi M, d'Abusco AS, Altieri F, Lascu I, Turano C and Giartosio A: DNA sequences acting as binding sites for NM23/NDPK proteins in melanoma M14 cells. J Cell Biochem 98: 421-428, 2006.
10. Cervoni L, Pietrangeli P, Chichiarelli S, Altieri F, Egistelli L, Turano C, Lascu I and Giartosio A: In vivo cross-linking of nm23/nucleoside diphosphate kinase to the PDGF-A gene promoter. Mol Biol Rep 30: 33-40, 2003.
11. Chang W, Ma L, Lin L, Gu L, Liu X, Cai H, Yu Y, Tan X, Zhai Y, Xu X, Zhang M, Wu L, Zhang H, Hou J, Wang H and Cao G: Identification of novel hub genes associated with liver metastasis of gastric cancer. Int J Cancer 125: 2844-2853, 2009.
12. Horak CE, Lee JH, Elkahloun AG, Boissan M, Dumont S, Maga TK, Arnaud-Dabernat S, Palmieri D, Stetler-Stevenson WG, Lacombe ML, Meltzer PS and Steeg PS: Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. Cancer Res 67: 7238-7246, 2007.
13. Arai T, Yamashita T, Urano T, Masunaga A, Itoyama S, Itoh K, Shiku H and Sugawara I: Preferential reduction of nm23-H1 gene product in metastatic tissues from papillary and follicular carcinomas of the thyroid. Mod Pathol 8: 252-256, 1995.
14. Liu Y, Jiang C and Tan Y: Pathological study on the expression of cell adhesion molecules and metastasis suppressor gene in thyroid follicular carcinoma and papillary carcinoma. Zhonghua Bing Li Xue Za Zhi 31: 322-326, 2002.
15. Wei Q and Fan S: Expression of CD44V6 and nm23-H1 in thyroid papillary adenocarcinoma and lymph node metastasis. Hunan Yi Ke Da Xue Xue Bao 23: 5-7, 30, 1998.
16. McLaughlin PJ, Zagon IS, Park SS, Conway A, Donahue RN and Goldenberg D: Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis. BMC Cancer 9: 369, 2009.
17. Mishra A, Ormerod AK, Cibull ML, Spear BT, Kraner SD and Kaetzel DM: PDGF-A promoter and enhancer elements provide efficient and selective antineoplastic gene therapy in multiple cancer types. Cancer Gene Ther 16: 298-309, 2009.
18. Gonzalez M, Ruggiero FP, Chang Q, Shi YJ, Rich MM, Kraner S and Balice-Gordon RJ: Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions. Neuron 24: 567-583, 1999.
19. Norris CM, Kadish I, Blalock EM, Chen KC, Thibault V, Porter NM, Landfield PW and Kraner SD: Calcineurin triggers reactive/inflammatory processes in astrocytes and is up-regulated in aging and Alzheimer's models. J Neurosci 25: 4649-4658, 2005.
20. Kanegae Y, Makimura M, Saito I: A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47: 157-166, 1994.
21. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264, 2003.
22. Xu L, Shen SS, Hoshida Y, Subramanian A, Ross K, Brunet JP, Wagner SN, Ramaswamy S, Mesirov JP and Hynes RO: Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol Cancer Res 6: 760-769, 2008.
23. Kabbarah O, Nogueira C, Feng B, Nazarian RM, Bosenberg M, Wu M, Scott KL, Kwong LN, Xiao Y, Cordon-Cardo C, Granter SR, Ramaswamy S, Golub T, Duncan LM, Wagner SN, Brennan C and Chin L: Integrative genome comparison of primary and metastatic melanomas. PLoS One 5: e10770, 2010.
24. Madden SF, Clarke C, Gaule P, Aherne ST, O'Donovan N, Clynes M, Crown J and Gallagher WM: BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome. Breast Cancer Res 15: R52, 2013.
25. Fiore LS, Ganguly SS, Sledziona J, Cibull ML, Wang C, Richards DL, Neltner JM, Beach C, McCorkle JR, Kaetzel DM and Plattner R: c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer. Oncogene, in press.
26. Benjamini Y and Hochberg Y: Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological 57: 289-300, 1995.
27. De S, Cipriano R, Jackson MW and Stark GR: Overexpression of kinesins mediates docetaxel resistance in breast cancer cells. Cancer Res 69: 8035-8042, 2009.
28. Koh CG, Tan EJ, Manser E and Lim L: The p21-activated kinase PAK is negatively regulated by POPX1 and POPX2, a pair of serine/threonine phosphatases of the PP2C family. Curr Biol 12: 317-321, 2002.
29. Horak CE, Mendoza A, Vega-Valle E, Albaugh M, Graff-Cherry C, McDermott WG, Hua E, Merino MJ, Steinberg SM, Khanna C and Steeg PS: Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2. Cancer Res 67: 11751-11759, 2007.
30. Yang M, Jarrett SG, Craven R and Kaetzel DM: YNK1, the yeast homolog of human metastasis suppressor NM23, is required for repair of UV radiation- and etoposide-induced DNA damage. Mutat Res 660: 74-78, 2009.
31. Bornhauser BC, Olsson PA and Lindholm D: MSAP is a novel MIR-interacting protein that enhances neurite outgrowth and increases myosin regulatory light chain. J Biol Chem 278: 35412-35420, 2003.
32. Voura EB, Ramjeesingh RA, Montgomery AM and Siu CH: Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol Biol Cell 12: 2699-2710, 2001.
33. Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Fujimura L, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nakagawa M, Katayama A, Harabuchi Y, Okamoto Y and Seki N: Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma. Br J Cancer 105: 833- 841, 2011.
34. Brems-Eskildsen AS, Zieger K, Toldbod H, Holcomb C, Higuchi R, Mansilla F, Munksgaard PP, Borre M, Orntoft TF and Dyrskjot L: Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts. BMC Cancer 10: 646, 2010.
35. Shevde LA, Samant RS, Goldberg SF, Sikaneta T, Alessandrini A, Donahue HJ, Mauger DT, Welch DR: Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp Cell Res 273: 229-239, 2002.
36. Riker AI and Samant RS: Location, location, location: The BRMS1 protein and melanoma progression. BMC Med 10: 19, 2012.
37. Liu H, Kato Y, Erzinger SA, Kiriakova GM, Qian Y, Palmieri D, Steeg PS and Price JE: The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model. BMC Cancer 12: 583, 2012.
38. Huang Y, Song N, Ding Y, Yuan S, Li X, Cai H, Shi H and Luo Y: Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis. Cancer Res 69: 7529-7537, 2009.
39. Melnikova VO and Bar-Eli M: Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL- 8. Pigment Cell Res 19: 395-405, 2006.
40. Luis-Ravelo D, Anton I, Zandueta C, Valencia K, Ormazabal C, Martinez-Canarias S, Guruceaga E, Perurena N, Vicent S, De Las Rivas J and Lecanda F: A gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer. Oncogene 2013.
41. Wang J, Cui S, Zhang X, Wu Y and Tang H: High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer. PLoS One 8: e62876, 2013.
42. Hurley PJ, Marchionni L, Simons BW, Ross AE, Peskoe SB, Miller RM, Erho N, Vergara IA, Ghadessi M, Huang Z, Gurel B, Park BH, Davicioni E, Jenkins RB, Platz EA, Berman DM and Schaeffer EM: Secreted protein, acidic and rich in cysteinelike 1 (SPARCL1) is down-regulated in aggressive prostate cancers and is prognostic for poor clinical outcome. Proc Natl Acad Sci USA 109: 14977-14982, 2012.
43. Cao F, Wang K, Zhu R, Hu YW, Fang WZ and Ding HZ: Clinicopathological significance of reduced SPARCL1 expression in human breast cancer. Asian Pac J Cancer Prev 14: 195-200, 2013.
44. Hu H, Zhang H, Ge W, Liu X, Loera S, Chu P, Chen H, Peng J, Zhou L, Yu S, Yuan Y, Zhang S, Lai L, Yen Y and Zheng S: Secreted protein acidic and rich in cysteines-like 1 suppresses aggressiveness and predicts better survival in colorectal cancers. Clin Cancer Res 18: 5438-5448, 2012.
45. Chung CC, Kanetsky PA, Wang Z, Hildebrandt MA, Koster R, Skotheim RI, Kratz CP, Turnbull C, Cortessis VK, Bakken AC, Bishop DT, Cook MB, Erickson RL, Fossa SD, Jacobs KB, Korde LA, Kraggerud SM, Lothe RA, Loud JT, Rahman N, Skinner EC, Thomas DC, Wu X, Yeager M, Schumacher FR, Greene MH, Schwartz SM, McGlynn KA, Chanock SJ and Nathanson KL: Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet 45: 680-685, 2013.
46. Mao B, Hu F, Cheng J, Wang P, Xu M, Yuan F, Meng S, Wang Y, Yuan Z and Bi W: SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma. Oncogene 33: 1468-1474, 2014.
47. Xia Y, Chang T, Wang Y, Liu Y, Li W, Li M and Fan HY: YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients. PLoS One 9: e91770, 2014.
48. Marino N, Marshall JC and Steeg PS: Protein-protein interactions: a mechanism regulating the anti-metastatic properties of Nm23-H1. Naunyn Schmiedebergs Arch Pharmacol 384: 351-362, 2011.